SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-180730
Filing Date
2019-06-25
Accepted
2019-06-25 08:00:58
Documents
14
Period of Report
2019-06-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d723820d8k.htm 8-K 20148
2 EX-99.1 d723820dex991.htm EX-99.1 12555
3 EX-99.2 d723820dex992.htm EX-99.2 14372
4 GRAPHIC g723820ex99_1s10g1.jpg GRAPHIC 285282
5 GRAPHIC g723820ex99_1s1g1.jpg GRAPHIC 287879
6 GRAPHIC g723820ex99_1s2g1.jpg GRAPHIC 501738
7 GRAPHIC g723820ex99_1s3g1.jpg GRAPHIC 338537
8 GRAPHIC g723820ex99_1s4g1.jpg GRAPHIC 229494
9 GRAPHIC g723820ex99_1s5g1.jpg GRAPHIC 231776
10 GRAPHIC g723820ex99_1s6g1.jpg GRAPHIC 283285
11 GRAPHIC g723820ex99_1s7g1.jpg GRAPHIC 293468
12 GRAPHIC g723820ex99_1s8g1.jpg GRAPHIC 297312
13 GRAPHIC g723820ex99_1s9g1.jpg GRAPHIC 237996
14 GRAPHIC g723820g0624164819393.jpg GRAPHIC 2966
  Complete submission text file 0001193125-19-180730.txt   4167287
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 19916930
SIC: 2834 Pharmaceutical Preparations